Abstract:Lipid droplets (LD) have long been considered as mere fat drops; however, LD have lately been revealed to be ubiquitous, dynamic and to be present in diverse organelles in which they have a wide range of key functions. Although incompletely understood, the biogenesis of eukaryotic LD initiates with the synthesis of neutral lipids (NL) by enzymes located in the endoplasmic reticulum (ER). The accumulation of NL leads to their segregation into nanometric nuclei which then grow into lenses between the ER leaflets as they are further filled with NL. The lipid composition and interfacial tensions of both ER and the lenses modulate their shape which, together with specific ER proteins, determine the proneness of LD to bud from the ER toward the cytoplasm. The most important function of LD is the buffering of energy. But far beyond this, LD are actively integrated into physiological processes, such as lipid metabolism, control of protein homeostasis, sequestration of toxic lipid metabolic intermediates, protection from stress, and proliferation of tumours. Besides, LD may serve as platforms for pathogen replication and defense. To accomplish these functions, from biogenesis to breakdown, eukaryotic LD have developed mechanisms to travel within the cytoplasm and to establish contact with other organelles. When nutrient deprivation occurs, LD undergo breakdown (lipolysis), which begins with the LD-associated members of the perilipins family PLIN2 and PLIN3 chaperone-mediated autophagy degradation (CMA), a specific type of autophagy that selectively degrades a subset of cytosolic proteins in lysosomes. Indeed, PLINs CMA degradation is a prerequisite for further true lipolysis, which occurs via cytosolic lipases or by lysosome luminal lipases when autophagosomes engulf portions of LD and target them to lysosomes. LD play a crucial role in several pathophysiological processes. Increased accumulation of LD in non-adipose cells is commonly observed in numerous infectious diseases caused by intracellular pathogens including viral, bacterial, and parasite infections, and is gradually recognized as a prominent characteristic in a variety of cancers. This review discusses current evidence related to the modulation of LD biogenesis and breakdown caused by intracellular pathogens and cancer.

Small, fat-filled lipid droplets remain spherical as they indent a nucleus, dilute the lamina, and cause rupture

The Nucleus Bypasses Obstacles by Deforming Like a Drop with Surface Tension Mediated by Lamin A/C

Imaging lipid droplet fusion and growth.

Running ‘LAPS’ Around nLD: Nuclear Lipid Droplet Form and Function

A gel-like condensation of Cidec generates lipid-permeable plates for lipid droplet fusion

Key Factors Governing Initial Stages of Lipid Droplet Formation

NUCLEAR LIPID DROPLETS IN CACO2 CELLS ORIGINATE FROM NASCENT PRECURSORS AND IN SITU AT THE NUCLEAR ENVELOPE

Linkage between lipid droplet formation and nuclear deformation in HeLa human cervical cancer cells

Hemifusomes and Interacting Proteolipid Nanodroplets: Formation of a Novel Cellular Organelle Complex

Dynamically arrested condensate fusion creates complex structures with varying material properties

Dynamical modelling of lipid droplet formation suggests a key function of membrane phospholipids

Lipid Droplet Nucleation

Lipid droplets as substrates for protein phase separation

Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions

Viscous shaping of the compliant cell nucleus

Specific Spatial Localization of Actin and DNA in a Water/Water Microdroplet: Self-Emergence of a Cell-Like Structure

Hepatocytes Deficient in Nuclear Envelope Protein Lamina-associated Polypeptide 1 are an Ideal Mammalian System to Study Intranuclear Lipid Droplets

Lipid droplet motility and organelle contacts

Lipid droplets and fatty acid‐induced lipotoxicity: in a nutshell

Stepwise Biogenesis of Subpopulations of Lipid Droplets in Nitrogen Starved Phaeodactylum tricornutum Cells

Nuclear lipid droplets - how are they different from their cytoplasmic siblings?